A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Clinical trial NCT01689532 · COMPLETED
Trial details
- NCT number
- NCT01689532
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-03-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.